| 1 |
15200054 | Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling. | 2004 Apr |
1 |
| 2 |
11721009 | Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism. | 2001 Dec |
1 |
| 3 |
9021406 | Augmentation of immune response by an analog of the antigenic peptide in a human T-cell clone recognizing mutated Ras-derived peptides. | 1997 Jan |
1 |
| 4 |
9311595 | Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. | 1997 Sep 4 |
1 |
| 5 |
9398294 | Structural and biochemical characterization of the GTPgammaS-, GDP.Pi-, and GDP-bound forms of a GTPase-deficient Gly42 --> Val mutant of Gialpha1. | 1997 Dec 16 |
1 |
| 6 |
8747433 | Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins. | 1995 Nov |
1 |
| 7 |
1639630 | T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. | 1992 Apr |
1 |
| 8 |
1652268 | Ras proteins activate calcium channels in neuronal cells. | 1991 |
9 |
| 9 |
2014702 | [The role of "valine substitution" in oncogene functioning (a hypothesis)]. | 1991 |
2 |
| 10 |
2483936 | Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes. | 1989 Dec |
1 |
| 11 |
2508560 | Site-directed mutagenesis of the GDP binding domain of bacterial elongation factor Tu. | 1989 Nov 1 |
1 |
| 12 |
2567085 | Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms. | 1989 |
1 |
| 13 |
2642607 | Structural differences between a ras oncogene protein and the normal protein. | 1989 Jan 5 |
2 |
| 14 |
2669815 | Conformational effects of amino acid substitutions at positions 10, 12, and 13 in the P21 protein. | 1989 Feb |
1 |
| 15 |
2682005 | Ras gene activation and epidermal growth factor receptor expression in human colon cancer. | 1989 Nov |
1 |
| 16 |
2686707 | Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form. | 1989 Apr |
2 |
| 17 |
2785386 | Comparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments. | 1989 Apr 14 |
1 |
| 18 |
3277185 | Chimeric proteins define variable and essential regions of Ha-ras-encoded protein. | 1988 Feb |
2 |
| 19 |
3313005 | Heterologous expression and characterization of the human R-ras gene product. | 1987 Aug |
1 |
| 20 |
3082814 | Synthesis and expression of a synthetic gene for the activated human c-Ha-ras protein. | 1986 Jan |
1 |
| 21 |
3332015 | Teratocarcinoma derived from mouse zygotes after the introduction of activated human c-Ha-ras DNA. | 1986 |
1 |
| 22 |
3919305 | Yeast and mammalian ras proteins have conserved biochemical properties. | 1985 Feb 21-27 |
1 |
| 23 |
6308640 | Spontaneous activation of a human proto-oncogene. | 1983 Aug |
2 |
| 24 |
7133135 | A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. | 1982 Nov 11 |
1 |